Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia

By Lowe F.C.   McDaniel R.L.   Chmiel J.J.   Hillman A.L.  

Urology, Vol. 46, Iss. 4, 1995-10 ,pp. : 477-483

Elsevier

Access to resources Recommend Favorite

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia

By Elhilali M.M.   Ramsey E.W.   Barkin J.   Casey R.W.   Boake R.C.   Beland G.   Fradet Y.   Trachtenberg J.   Orovan W.L.   Schick E.   Klotz L.H.  

Urology, Vol. 47, Iss. 3, 1996-03 ,pp. : 335-342

Elsevier

Access to resources Recommend Favorite

Meta-analysis of randomized trials of terazosin in the treatment of benign prostatic hyperplasia

By Boyle P.   Robertson C.   Manski R.   Padley R.J.   Roehrborn C.G.  

Urology, Vol. 58, Iss. 5, 2001-11 ,pp. : 717-722

Elsevier

Access to resources Recommend Favorite

The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia

By Roehrborn C.G.   Oesterling J.E.   Auerbach S.   Kaplan S.A.   Lloyd L.K.   Milam D.F.   Padley R.J.  

Urology, Vol. 47, Iss. 2, 1996-02 ,pp. : 159-168

Elsevier

Access to resources Recommend Favorite

A Cost-Effectiveness Analysis of Transurethral Resection of the Prostate and Transurethral Microwave Thermotherapy for Treatment of Benign Prostatic Hyperplasia: Two-Year Follow-up

By Waldén Mauritz   Acosta Stefan   Carlsson Per   Pettersson Silas   Dahlstrand Christer  

Scandinavian Journal of Urology and Nephrology, Vol. 32, Iss. 3, 1998-06 ,pp. : 204-210

Informa Healthcare

Access to resources Recommend Favorite